Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC naming Pádraig O'Sullivan .
Filed returns
11
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on patient access to new medicines (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with Oireachtas members to promote shared industry priorities ahead of GE 2024 (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government & Oireachtas members re new medicines funding. (Matters involving public funds) | 7 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Informal meeting with Pádraig O'Sullivan TD (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Oireachtas members on the need for new development funding for new medicines reimbursements in 2024 (Matters involving public funds) | 24 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members on reform of the reimbursement process for newly approved medicines (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2023 | Janssen Sciences Ireland UC | Health | Sharing Information and views on medicines reimbursement reform and patient access (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Highlighting the importance of STEM education & apprenticeship training for pharmaceutical industry in Ireland as well as need for continued investment in local infrastructure (Public policy or programme) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 63.6% | |
| Budgetary matters | 2 | 18.2% | |
| Economic Development and Industry | 2 | 18.2% |